Pediatric migraine: new diagnostic strategies and treatment options.
Migraine headaches are seen commonly by physicians caring for children and adolescents. The prevalence in the pediatric population ranges from 3.2 to 10.6%. With the advent of new inclusive diagnostic criteria, reproducibility of definitive diagnosis in children and adolescents should improve. Although advances with clinical drug trials have yielded new, approved therapies in adults, information remains inconclusive in the pediatric population. Further clinical studies are warranted to develop consensus on treatment paradigms for clinicians to utilize in children and adolescents with migraine.
Pakalnis
Ann
A
Headache Clinic, Columbus Children's Hospital, Ohio State University College of Medicine, Columbus, OH, USA. PakalnisA@pediatrics.ohio-state.edu
D000293:Adolescent; D000700:Analgesics / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D002648:Child; D006801:Humans; D008881:Migraine Disorders / Q000175:diagnosis* / Q000188:drug therapy*
D000700:Analgesics; D000927:Anticonvulsants